Nicholas Harre

Life Science Research Professional

  • B.S. 2012. Chemical Engineering, University of California San Diego       

Research Interests

I was thrilled to join Stanford’s newly formed Center for Genetic Immune Diseases (CeGID) after my experience researching the complexities of transplantation and rejection at UCLA’s Immunogenetics Center. CeGID aims to transform the lives of patients with immune deficiencies by uncovering the genetic causes of their diseases, developing innovative treatments, and eventually curing patients. My specific role within this center involves designing advanced diagnostic assays for phenotyping and functional assessment of immune cells to validate genetic mutations as pathogenic causes of disease. More broadly, I work to investigate novel gene mutations in order to provide a better understanding of damaged pathways and human biology, with the ultimate goal of discovering new and innovative treatments for a diverse and unique population of patients.



  1. Sosa RA, Zarrinpar A, Rossetti M, Lassman CR, Datta N, Rao P, Harre N, Zheng Y, Spreafico R, Hoffman A, Busuttil RW, Gjertson DR, Kupiec-Weglinski JW, Reed EF. Early Cytokine Signatures of Ischemia Reperfusion Injury in Human Orthotopic Liver Transplantation. JCI Insight. 2016 Oct 25. 
  2. Schaenman JM, Korin Y, Sidwell T, Kandarian F, Harre N, Gjertson D, Lum EL, Reddy U, Huang E, Pham PT, Bunnapradist S, Danovitch GM, Veale J, Gritsch HA, Reed EF. Increased Frequency of BK Virus-Specific Polyfunctional CD8+ T Cells Predict Successful Control of BK Viremia After Kidney Transplantation. Transplantation. 2016 Jul 7.

Related sites